Evidence map›Paper›PMID 40459924›Full record

ArticleJournal of medical Internet research2025

Longitudinal Digital Phenotyping of Multiple Sclerosis Severity Using Passively Sensed Behaviors and Ecological Momentary Assessments: Real-World Evaluation.

Zongqi Xia, Prerna Chikersal, Shruthi Venkatesh, Elizabeth Walker, Anind K Dey, Mayank Goel

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Zongqi Xia *Department of Neurology, University of Pittsburgh, Pittsburgh, PA, United States.ORCID https://orcid.org/0000-0003-1500-2589
Prerna ChikersalSchool of Computer Science, Carnegie Mellon University, Pittsburgh, PA, United States.ORCID https://orcid.org/0000-0002-0961-6210
Shruthi VenkateshDepartment of Neurology, University of Pittsburgh, Pittsburgh, PA, United States.ORCID https://orcid.org/0000-0001-9113-0502
Elizabeth WalkerDepartment of Neurology, University of Pittsburgh, Pittsburgh, PA, United States.ORCID https://orcid.org/0000-0002-6294-1098
Anind K DeyInformation School, University of Washington, Seattle, WA, United States.ORCID https://orcid.org/0000-0002-3004-0770
Mayank Goel *School of Computer Science, Carnegie Mellon University, Pittsburgh, PA, United States.ORCID https://orcid.org/0000-0003-1237-7545

Funding

Leveraging electronic health records to optimize treatment selection and response in multiple sclerosisR01NS098023 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Zongqi Xia · 2016 to 2026
$4.6M
Real-world impact of the COVID-19 pandemic in people with multiple sclerosisR01NS124882 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI XIA, ZONGQI · 2022 to 2024
$1.2M
NINDS NIH HHS R01 NS098023NINDS NIH HHS R01 NS124882
6 · The paper itself

Abstract

backgroundLongitudinal tracking of multiple sclerosis (MS) symptoms in an individual's environment may improve self-monitoring and clinical management for people with MS. Conventional symptom tracking methods rely on self-reports and clinical visits, which can be infrequent, subjective, and burdensome. Digital phenotyping using passively collected sensor data from smartphones and fitness trackers offers a promising alternative for continuous, real-time symptom monitoring with minimal patient burden.

objectiveWe aimed to develop and evaluate a machine learning (ML)-based digital phenotyping approach to monitor the severity of clinically-relevant MS symptoms. We used passive sensing data to predict short-term fluctuations in patient-reported symptoms, including depressive symptoms, global MS symptom burden, severe fatigue, and poor sleep quality. Further, we examined the impact of incorporating behavioral context features and ecological momentary assessments on prediction performance.

methodsWe conducted a 12- to 24-week longitudinal study involving 104 people with MS, collecting passive sensor and behavioral health data. Smartphone sensors recorded call activity, location, and screen use, while fitness trackers captured heart rate, sleep patterns, and step count. We extracted patient-level behavioral features and categorized them into 2 feature sets: one from the prediction period (called action) and one from the preceding period (called context). Using an ML pipeline based on support vector machines and AdaBoost, we evaluated the predictive performance of sensor-based models, both with and without ecological momentary assessment inputs.

resultsBetween November 16, 2019, and January 24, 2021, overall, 104 people with MS (women: n=88, 84.6%; non-Hispanic White: n=97, 93.3%; mean age 44, SD 11.8 years) from a clinic-based cohort completed 12 weeks of data collection, including a subset of 44 participants (women: n=39, 89%; non-Hispanic White: n=42, 95%; mean age 45.7, SD 11.2 years) who completed 24 weeks of data collection. In total, we collected approximately 12,500 days of passive sensor and behavioral health data from the participants. Among the best-performing models with the least sensor data requirement, the ML algorithm predicted depressive symptoms with an accuracy of 80.6% (F

conclusionsOur digital phenotyping approach using passive sensors on smartphones and fitness trackers may help patients with real-world, continuous self-monitoring of common symptoms in their own environment and assist clinicians with better triage of patient needs for timely interventions in MS and potentially other chronic neurological disorders.

Indexed as

Ecological Momentary AssessmentMultiple SclerosisAdultFemaleFitness TrackersHumansLongitudinal StudiesMachine LearningMaleMiddle AgedPhenotypeSeverity of Illness IndexSmartphoneartificial intelligencedepressiondigital phenotypingdisabilityecological momentary assessmentsfatiguemachine learningmobile sensingmultiple sclerosissleepwearable

Identifiers

PMID40459924
PMCPMC12174892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.